Back to Search
Start Over
Monocyte-based microrobot with chemotactic motility for tumor theragnosis.
- Source :
-
Biotechnology and bioengineering [Biotechnol Bioeng] 2014 Oct; Vol. 111 (10), pp. 2132-8. Date of Electronic Publication: 2014 Jun 09. - Publication Year :
- 2014
-
Abstract
- Biocompatibility, sensing, and self-actuation are very important features for a therapeutic biomedical microrobot. As a new concept for tumor theragnosis, this paper proposes a monocyte-based microrobots, which are combining the phagocytosis and engulfment activities containing human acute monocytic leukemia cell line (THP-1) with various sized polystyrene microbeads are engulfed instead of a therapeutic drug. For the validation of the blood vessel barrier-penetrating activity of the monocyte-based microrobot, we fabricate a new cell migration assay with monolayer-cultured endothelial cell (HUVEC), similar with the blood vessels. We perform the penetrating chemotactic motility of the monocyte-based microrobot using various types of the chemo-attractants, such as monocyte chemotactic protein (MCP)-1, human breast cancer cell lines (MCF7)-cell lysates, and -contained alginate spheroids. The monocyte-based microrobot show chemotactic transmigrating motilities similar with what an actual monocyte does. This new paradigm of a monocyte-based microrobot having various useful properties such as biocompatibility, sensing, and self-actuation can become the basis of a biomedical microrobot using monocytes for diagnosis and therapy of various diseases.<br /> (© 2014 Wiley Periodicals, Inc.)
Details
- Language :
- English
- ISSN :
- 1097-0290
- Volume :
- 111
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- Biotechnology and bioengineering
- Publication Type :
- Academic Journal
- Accession number :
- 24771225
- Full Text :
- https://doi.org/10.1002/bit.25270